Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Arnold von Eckardstein

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Risk Factors

Disorders

Anatomy

Physiology

Biological Transport

Living Beings

Mice

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
81
Assmann, Gerd
19
Schulte, Helmut
18
Funke, Harald
14
Cullen, Paul
14
Junker, Ralf
11
Hersberger, Martin
11
Nofer, Jerzy-Roch
10
Rohrer, Lucia
9
Kronenberg, Florian
8
Langer, Claus
8
Fobker, Manfred
8
Rentsch, Katharina
7
Nowak-Göttl, Ulrike
7
Cignarella, Andrea
7
Chirazi, A

Sign-in to see all Coauthors

Publications

TOP 3
Rütti Sabine; Ehses Jan A; Sibler Rahel A; Prazak Richard; Rohrer Lucia; Georgopoulos Spiros; Meier Daniel T; Niclauss Nadja; Berney Thierry; Donath Marc Y; von Eckardstein Arnold
Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells.
Hornemann Thorsten; Penno Anke; Rütti Markus F; Ernst Daniela; Kivrak-Pfiffner Fatma; Rohrer Lucia; von Eckardstein Arnold
The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases.
Tamehiro Norimasa; Mujawar Zahedi; Zhou Suiping; Zhuang Debbie Z; Hornemann Thorsten; von Eckardstein Arnold; Fitzgerald Michael L
Cell polarity factor Par3 binds SPTLC1 and modulates monocyte serine palmitoyltransferase activity and chemotaxis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Arnold von Eckardstein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Rütti Sabine; Ehses Jan A; Sibler Rahel A; Prazak Richard; Rohrer Lucia; Georgopoulos Spiros; Meier Daniel T; Niclauss Nadja; Berney Thierry; Donath Marc Y; von Eckardstein Arnold
Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells.
Endocrinology 2009;150(10):4521-30.
2009: Hornemann Thorsten; Penno Anke; Rütti Markus F; Ernst Daniela; Kivrak-Pfiffner Fatma; Rohrer Lucia; von Eckardstein Arnold
The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases.
The Journal of biological chemistry 2009;284(39):26322-30.
2009: Tamehiro Norimasa; Mujawar Zahedi; Zhou Suiping; Zhuang Debbie Z; Hornemann Thorsten; von Eckardstein Arnold; Fitzgerald Michael L
Cell polarity factor Par3 binds SPTLC1 and modulates monocyte serine palmitoyltransferase activity and chemotaxis.
The Journal of biological chemistry 2009;284(37):24881-90.
2009: Bernini Franco; Freeman Dilys; Groen Albert; Heeren Jörg; Kalopissis Athina; Kronenberg Florian; Lindstedt Ken; Parini Paolo; Schuster Gertrud; Tybjaerg Hansen Anne; van Dij Ko Willems; von Eckardstein Arnold
European Lipoprotein Club: report of the 31st ELC Annual Conference, Tutzing, 8-11 September 2008.
Atherosclerosis 2009;205(1):41-7.
2009: von Eckardstein Arnold; Rohrer Lucia
Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins.
Current opinion in lipidology 2009;20(3):197-205.
2009: Rütti Markus F; Richard Stéphane; Penno Anke; von Eckardstein Arnold; Hornemann Thorsten
An improved method to determine serine palmitoyltransferase activity.
Journal of lipid research 2009;50(6):1237-44.
2009: Rohrer Lucia; Ohnsorg Pascale M; Lehner Marc; Landolt Franziska; Rinninger Franz; von Eckardstein Arnold
High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1.
Circulation research 2009;104(10):1142-50.
2009: Hof Danielle; von Eckardstein Arnold
[Risk factors in atherosclerotic coronary heart disease]
Therapeutische Umschau. Revue thérapeutique 2009;66(4):253-9.
2009: Hornemann Thorsten; Penno Anke; Richard Stephane; Nicholson Garth; van Dijk Fleur S; Rotthier Annelies; Timmerman Vincent; von Eckardstein Arnold
A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated.
Neurogenetics 2009;10(2):135-43.
2009: Dieplinger Benjamin; Mueller Thomas; Kollerits Barbara; Struck Joachim; Ritz Eberhard; von Eckardstein Arnold; Haltmayer Meinhard; Kronenberg Florian;
Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study.
Kidney international 2009;75(4):408-14.
2009: Karuna Ratna; von Eckardstein Arnold; Rentsch Katharina M
Dopant assisted-atmospheric pressure photoionization (DA-APPI) liquid chromatography-mass spectrometry for the quantification of 27-hydroxycholesterol in plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(3):261-8.
2008: Osto Elena; Kouroedov Alexei; Mocharla Pavani; Akhmedov Alexander; Besler Christian; Rohrer Lucia; von Eckardstein Arnold; Iliceto Sabino; Volpe Massimo; Lüscher Thomas F; Cosentino Francesco
Inhibition of protein kinase Cbeta prevents foam cell formation by reducing scavenger receptor A expression in human macrophages.
Circulation 2008;118(21):2174-82.
2008: Felber Dietrich Denise; Ackermann-Liebrich Ursula; Schindler Christian; Barthélémy Jean-Claude; Brändli Otto; Gold Diane R; Knöpfli Bruno; Probst-Hensch Nicole M; Roche Frédéric; Tschopp Jean-Marie; von Eckardstein Arnold; Gaspoz Jean-Michel;
Effect of physical activity on heart rate variability in normal weight, overweight and obese subjects: results from the SAPALDIA study.
European journal of applied physiology 2008;104(3):557-65.
2008: Zorzetto Michele; Russi Erich; Senn Oliver; Imboden Medea; Ferrarotti Ilaria; Tinelli Carmine; Campo Ilaria; Ottaviani Stefania; Scabini Roberta; von Eckardstein Arnold; Berger Wolfgang; Brändli Otto; Rochat Thierry; Luisetti Maurizio; Probst-Hensch Nicole;
SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations.
Clinical chemistry 2008;54(8):1331-8.
2008: Lorenzi Iris; von Eckardstein Arnold; Radosavljevic Silvija; Rohrer Lucia
Lipidation of apolipoprotein A-I by ATP-binding cassette transporter (ABC) A1 generates an interaction partner for ABCG1 but not for scavenger receptor BI.
Biochimica et biophysica acta 2008;1781(6-7):306-13.
2008: Tamehiro Norimasa; Zhou Suiping; Okuhira Keiichiro; Benita Yair; Brown Cari E; Zhuang Debbie Z; Latz Eicke; Hornemann Thorsten; von Eckardstein Arnold; Xavier Ramnik J; Freeman Mason W; Fitzgerald Michael L
SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporter.
Biochemistry 2008;47(23):6138-47.
2008: Rudiger Alain; Fischler Manuel; Harpes Paul; Gasser Stephan; Hornemann Thorsten; von Eckardstein Arnold; Maggiorini Marco
In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts.
International journal of cardiology 2008;126(1):28-31.
2008: Soltermann Alex; Ossola Reto; Kilgus-Hawelski Sandra; von Eckardstein Arnold; Suter Tobias; Aebersold Ruedi; Moch Holger
N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics.
Cancer 2008;114(2):124-33.
2008: Hofker Marten; Bernini Franco; von Eckardstein Arnold; Freeman Dilys; Heeren Joerg; Karpe Fredrik; Kalopissis Athina; Kronenberg Florian; Kuipers Folkert; Lindstedt Ken; Parini Paolo; Schuster Gertrud; van Dijk Ko Willems
European Lipoprotein Club: Report of the 30th ELC annual conference, Tutzing, 3-6 September 2007.
Atherosclerosis 2008;197(1):471-9.
2008: Lorenzi Iris; von Eckardstein Arnold; Cavelier Clara; Radosavljevic Silvija; Rohrer Lucia
Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.
Journal of molecular medicine (Berlin, Germany) 2008;86(2):171-83.
2008: Senn Oliver; Russi Erich W; Schindler Christian; Imboden Medea; von Eckardstein Arnold; Brändli Otto; Zemp Elisabeth; Ackermann-Liebrich Ursula; Berger Wolfgang; Rochat Thierry; Luisetti Maurizio; Probst-Hensch Nicole M;
Circulating alpha1-antitrypsin in the general population: determinants and association with lung function.
Respiratory research 2008;9():35.
2008: Lee-Rueckert Miriam; von Eckardstein Arnold; Kovanen Petri T
The neutral protease chymase degrades apolipoprotein E from high-density lipoproteins.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(3):421-3.
2007: Wronska-Nofer Teresa; Nofer Jerzy-Roch; Stetkiewicz Jan; Wierzbicka Malgorzata; Bolinska Halina; Fobker Manfred; Schulte Helmut; Assmann Gerd; von Eckardstein Arnold
Evidence for oxidative stress at elevated plasma thiol levels in chronic exposure to carbon disulfide (CS2) and coronary heart disease.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2007;17(7):546-53.
2007: Burkard Ines; von Eckardstein Arnold; Waeber Gérard; Vollenweider Peter; Rentsch Katharina M
Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers.
Atherosclerosis 2007;194(1):71-8.
2007: Hofker Marten; Calabresi Laura; von Eckardstein Arnold; Heeren Joerg; Karpe Fredrik; Kalopissis Athina; Kronenberg Florian; Kuipers Folkert; Lindstedt Ken; Parini Paolo; Schuster Gertrud; van Dijk Ko Willems
European Lipoprotein Club: Report of the 29th ELC Annual Conference, Tutzing, 4-7 September 2006.
Atherosclerosis 2007;193(2):461-8.
2007: Felber Dietrich Denise; Schwartz Joel; Schindler Christian; Gaspoz Jean-Michel; Barthélémy Jean-Claude; Tschopp Jean-Marie; Roche Frédéric; von Eckardstein Arnold; Brändli Otto; Leuenberger Philippe; Gold Diane R; Ackermann-Liebrich Ursula;
Effects of passive smoking on heart rate variability, heart rate and blood pressure: an observational study.
International journal of epidemiology 2007;36(4):834-40.
2007: Kawamura Akira; Baitsch Daniel; Telgmann Ralph; Feuerborn Renata; Weissen-Plenz Gabriele; Hagedorn Claudia; Saku Keijiro; Brand-Herrmann Stefan-Martin; von Eckardstein Arnold; Assmann Gerd; Nofer Jerzy-Roch
Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(7):1610-7.
2007: Spanaus Katharina-Susanne; Kronenberg Florian; Ritz Eberhard; Schlapbach Ralph; Fliser Danilo; Hersberger Martin; Kollerits Barbara; König Paul; von Eckardstein Arnold;
B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.
Clinical chemistry 2007;53(7):1264-72.
2007: Hornemann Thorsten; Wei Yu; von Eckardstein Arnold
Is the mammalian serine palmitoyltransferase a high-molecular-mass complex?
The Biochemical journal 2007;405(1):157-64.
2007: Buyken Anette E; von Eckardstein Arnold; Schulte Helmut; Cullen Paul; Assmann Gerd
Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2007;14(2):230-6.
2007: Altwegg Lukas A; Neidhart Michel; Hersberger Martin; Müller Simone; Eberli Franz R; Corti Roberto; Roffi Marco; Sütsch Gabor; Gay Steffen; von Eckardstein Arnold; Wischnewsky Manfred B; Lüscher Thomas F; Maier Willibald
Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes.
European heart journal 2007;28(8):941-8.
2007: Uehara Yoshinari; Miura Shin-ichiro; von Eckardstein Arnold; Abe Satomi; Fujii Akihiro; Matsuo Yoshino; Rust Stephan; Lorkowski Stefan; Assmann Gerd; Yamada Tatsuo; Saku Keijiro
Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element.
Atherosclerosis 2007;191(1):11-21.
2007: Shayanfar Noushin; Tobler Ulrich; von Eckardstein Arnold; Bestmann Lukas
Automated urinalysis: first experiences and a comparison between the Iris iQ200 urine microscopy system, the Sysmex UF-100 flow cytometer and manual microscopic particle counting.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2007;45(9):1251-6.
2006: Hornemann Thorsten; Richard Stephane; Rütti Markus F; Wei Yu; von Eckardstein Arnold
Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase.
The Journal of biological chemistry 2006;281(49):37275-81.
2006: Cavelier Clara; Rohrer Lucia; von Eckardstein Arnold
ATP-Binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells.
Circulation research 2006;99(10):1060-6.
2006: Lingenhel Arno; Lhotta Karl; Neyer Ulrich; Heid Iris M; Rantner Barbara; Kronenberg Martina F; König Paul; von Eckardstein Arnold; Schober Maria; Dieplinger Hans; Kronenberg Florian
Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria.
Journal of lipid research 2006;47(9):2071-9.
2006: Rudiger Alain; Gasser Stefan; Fischler Manuel; Hornemann Thorsten; von Eckardstein Arnold; Maggiorini Marco
Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
Critical care medicine 2006;34(8):2140-4.
2006: Felber Dietrich Denise; Schindler Christian; Schwartz Joel; Barthélémy Jean-Claude; Tschopp Jean-Marie; Roche Frédéric; von Eckardstein Arnold; Brändli Otto; Leuenberger Philipppe; Gold Diane R; Gaspoz Jean-Michel; Ackermann-Liebrich Ursula;
Heart rate variability in an ageing population and its association with lifestyle and cardiovascular risk factors: results of the SAPALDIA study.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2006;8(7):521-9.
2006: Cavelier Clara; Lorenzi Iris; Rohrer Lucia; von Eckardstein Arnold
Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
Biochimica et biophysica acta 2006;1761(7):655-66.
2006: Wollmer M Axel; Kapaki Elisabeth; Hersberger Martin; Muntwyler Jörg; Brunner Fabienne; Tsolaki Magdalini; Akatsu Hiroyasu; Kosaka Kenji; Michikawa Makoto; Molyva Dimitra; Paraskevas Giorgos P; Lütjohann Dieter; von Eckardstein Arnold; Hock Christoph; Nitsch Roger M; Papassotiropoulos Andreas
Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2006;141B(5):534-6.
2006: von Eckardstein Arnold
Differential diagnosis of familial high density lipoprotein deficiency syndromes.
Atherosclerosis 2006;186(2):231-9.
2006: Nofer Jerzy-Roch; Remaley Alan T; Feuerborn Renata; Wolinnska Iza; Engel Thomas; von Eckardstein Arnold; Assmann Gerd
Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter.
Journal of lipid research 2006;47(4):794-803.
2006: Nitsch Dorothea; Felber Dietrich Denise; von Eckardstein Arnold; Gaspoz Jean-Michel; Downs Sara H; Leuenberger Philippe; Tschopp Jean-Marie; Brändli Otto; Keller Roland; Gerbase Margaret W; Probst-Hensch Nicole M; Stutz Elisabeth Zemp; Ackermann-Liebrich Ursula;
Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(4):935-44.
2006: Gessler Peter; Knirsch Walter; Schmitt Bernhard; Rousson Valentin; von Eckardstein Arnold
Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery.
The Journal of pediatrics 2006;148(3):372-6.
2006: Thelen Karin M; Rentsch Katharina M; Gutteck Ursula; Heverin Maura; Olin Maria; Andersson Ulla; von Eckardstein Arnold; Björkhem Ingemar; Lütjohann Dieter
Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
The Journal of pharmacology and experimental therapeutics 2006;316(3):1146-52.
2006: Rohrer Lucia; Cavelier Clara; Fuchs Séverine; Schlüter Marc Alexander; Völker Wolfgang; von Eckardstein Arnold
Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells.
Biochimica et biophysica acta 2006;1761(2):186-94.
2006: Reitz Christiane; Kretzschmar Konrad; Roesler Andreas; von Eckardstein Arnold; Berger Klaus
Relation of plasma thyroid-stimulating hormone levels to vascular lesions and atrophy of the brain in the elderly.
Neuroepidemiology 2006;27(2):89-95.
2005: Burkard Ines; von Eckardstein Arnold; Rentsch Katharina M
Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;826(1-2):147-59.
2005: Assmann Gerd; Cullen Paul; Fruchart Jean-Charles; Greten Heiner; Naruszewicz Marek; Olsson Anders; Paoletti Rodolfo; Riesen Walter; Stoll Monika; Tikkanen Matti; von Eckardstein Arnold;
Implications of emerging risk factors for therapeutic intervention.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2005;15(5):373-81.
2005: Hersberger Martin; Muntwyler Jörg; Funke Harald; Marti-Jaun Jacqueline; Schulte Helmut; Assmann Gerd; Lüscher Thomas F; von Eckardstein Arnold
The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction.
Clinical chemistry 2005;51(7):1110-5.
2005: Krause Manuela; Sonntag Barbara; Klamroth Robert; Heinecke Achim; Scholz Carola; Langer Claus; Scharrer Inge; Greb Robert R; von Eckardstein Arnold; Nowak-Göttl Ulrike
Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control study.
Thrombosis and haemostasis 2005;93(5):867-71.
2005: Cignarella Andrea; Engel Thomas; von Eckardstein Arnold; Kratz Mario; Lorkowski Stefan; Lueken Aloys; Assmann Gerd; Cullen Paul
Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors.
Atherosclerosis 2005;179(2):229-36.
2005: Maier Willibald; Altwegg Lukas A; Corti Roberto; Gay Steffen; Hersberger Martin; Maly Friedrich E; Sütsch Gabor; Roffi Marco; Neidhart Michel; Eberli Franz R; Tanner Felix C; Gobbi Sharon; von Eckardstein Arnold; Lüscher Thomas F
Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.
Circulation 2005;111(11):1355-61.
2005: von Eckardstein Arnold; Hersberger Martin; Rohrer Lucia
Current understanding of the metabolism and biological actions of HDL.
Current opinion in clinical nutrition and metabolic care 2005;8(2):147-52.
2005: Hersberger M; von Eckardstein A
Modulation of high-density lipoprotein cholesterol metabolism and reverse cholesterol transport.
Handbook of experimental pharmacology 2005;(170):537-61.
2005: von Eckardstein A
Risk factors for atherosclerotic vascular disease.
Handbook of experimental pharmacology 2005;(170):71-105.
2004: Wusk Barbara; Kullak-Ublick Gerd A; Rammert Christina; von Eckardstein Arnold; Fried Michael; Rentsch Katharina M
Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis.
European journal of gastroenterology & hepatology 2004;16(12):1407-13.
2004: Fischer Frank; Schulte Helmut; Mohan Subburaman; Tataru Mira-Christine; Köhler Ekkehart; Assmann Gerd; von Eckardstein Arnold
Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.
Clinical endocrinology 2004;61(5):595-602.
2004: Kronenberg Florian; Lingenhel Arno; Lhotta Karl; Rantner Barbara; Kronenberg Martina F; König Paul; Thiery Joachim; Koch Michael; von Eckardstein Arnold; Dieplinger Hans
Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
Kidney international 2004;66(1):348-54.
2004: Rohrer Lucia; Hersberger Martin; von Eckardstein Arnold
High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease.
Current opinion in lipidology 2004;15(3):269-78.
2004: Rüegg Christian; Hersberger Martin; Wusk Barbara; Rentsch Katharina; Kullak-Ublick Gerd A; von Eckardstein Arnold; Maly Friedrich E
Detection of the Arg702Trp, Gly908Arg and Leu1007fsinsC polymorphisms of the NOD2/CARD15 gene by real-time PCR with melting curve analysis.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2004;42(5):494-8.
2004: Hersberger Martin; Nusbaumer Charly; Scholer André; Knöpfli Verena; von Eckardstein Arnold
Influence of practicable virus inactivation procedures on tests for frequently measured analytes in plasma.
Clinical chemistry 2004;50(5):944-6.
2004: von Eckardstein Arnold
Is there a need for novel cardiovascular risk factors?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(4):761-5.
2004: Burkard Ines; Rentsch Katharina M; von Eckardstein Arnold
Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry.
Journal of lipid research 2004;45(4):776-81.
2004: Hofker M; Calabresi L; Jauhiainen M; Nimpf J; Rudling M; Talmud P; Mooser V; Dallinga-Thie G; von Eckardstein A; Staels B; Karpe F; Kuipers F
European Lipoprotein Club: report of the 26th ELC Annual Conference, Tutzing, 8-11 September 2003.
Atherosclerosis 2004;173(1):125-34.
2004: Wusk Barbara; Kullak-Ublick G A; Rammert C; von Eckardstein A; Fried M; Rentsch K M
Thiopurine S-methyltransferase polymorphisms: efficient screening method for patients considering taking thiopurine drugs.
European journal of clinical pharmacology 2004;60(1):5-10.
2004: Kronenberg Florian; Lingenhel Arno; Lhotta Karl; Rantner Barbara; Kronenberg Martina F; König Paul; Thiery Joachim; Koch Michael; von Eckardstein Arnold; Dieplinger Hans
The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome.
Kidney international 2004;65(2):606-12.
2004: von Eckardstein Arnold
Novel risk factors for atherosclerosis.
JAMA : the journal of the American Medical Association 2004;291(3):301; author reply 301-2.
2003: Heller Christine; Heinecke Achim; Junker Ralf; Knöfler Ralf; Kosch Andrea; Kurnik Karin; Schobess Rosemarie; von Eckardstein Arnold; Sträter Ronald; Zieger Barbara; Nowak-Göttl Ulrike;
Cerebral venous thrombosis in children: a multifactorial origin.
Circulation 2003;108(11):1362-7.
2003: Kratz Mario; Wahrburg Ursel; von Eckardstein Arnold; Ezeh Benjie; Assmann Gerd; Kronenberg Florian
Dietary mono- and polyunsaturated fatty acids similarly increase plasma apolipoprotein A-IV concentrations in healthy men and women.
The Journal of nutrition 2003;133(6):1821-5.
2003: Wu Fredrick C W; von Eckardstein Arnold
Androgens and coronary artery disease.
Endocrine reviews 2003;24(2):183-217.
2003: Cullen Paul; Baetta Roberta; Bellosta Stefano; Bernini Franco; Chinetti Giulia; Cignarella Andrea; von Eckardstein Arnold; Exley Andrew; Goddard Martin; Hofker Marten; Hurt-Camejo Eva; Kanters Edwin; Kovanen Petri; Lorkowski Stefan; McPheat William; Pentikäinen Markku; Rauterberg Jürgen; Ritchie Andrew; Staels Bart; Weitkamp Benedikt; de Winther Menno;
Rupture of the atherosclerotic plaque: does a good animal model exist?
Arteriosclerosis, thrombosis, and vascular biology 2003;23(4):535-42.
2003: Bowyer David; Dallinga-Thie Geesje; von Eckardstein Arnold; Hofker Marten; Jauhiainen Matti; Mooser Vincent; Nimpf Johannes; Rudling Matts; Staels Bart; Talmud Philippa
European lipoprotein club: report of the 25th ELC annual conference. Tutzing, 9-12 September 2002.
Atherosclerosis 2003;167(1):159-68.
2003: Chroni Angeliki; Liu Tong; Gorshkova Irina; Kan Horng-Yuan; Uehara Yoshinari; Von Eckardstein Arnold; Zannis Vassilis I
The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
The Journal of biological chemistry 2003;278(9):6719-30.
2003: Zitzmann M; Gromoll J; von Eckardstein A; Nieschlag E
The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men.
Diabetologia 2003;46(1):31-9.
2003: von Eckardstein Arnold; Crook David; Elbers Jolanda; Ragoobir Jennifer; Ezeh Benjamin; Helmond Frans; Miller Norman; Dieplinger Hans; Bennink Herjan Coelingh; Assmann Gerd
Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux.
Clinical endocrinology 2003;58(1):49-58.
2003: Hersberger Martin; von Eckardstein Arnold
Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.
Drugs 2003;63(18):1907-45.
2002: Lee Miriam; Sommerhoff Christian P; von Eckardstein Arnold; Zettl Frank; Fritz Hans; Kovanen Petri T
Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(12):2086-91.
2002: Sträter Ronald; Becker Sabine; von Eckardstein Arnold; Heinecke Achim; Gutsche Sven; Junker Ralf; Kurnik Karin; Schobess Rosemarie; Nowak-Göttl Ulrike
Prospective assessment of risk factors for recurrent stroke during childhood--a 5-year follow-up study.
Lancet 2002;360(9345):1540-5.
2002: Kratz Mario; von Eckardstein Arnold; Fobker Manfred; Buyken Anette; Posny Nicole; Schulte Helmut; Assmann Gerd; Wahrburg Ursel
The impact of dietary fat composition on serum leptin concentrations in healthy nonobese men and women.
The Journal of clinical endocrinology and metabolism 2002;87(11):5008-14.
2002: Horter M J; Sondermann S; Reinecke H; Bogdanski J; Woltering A; Kerber S; Breithardt G; Assmann G; Von Eckardstein A
Associations of HDL phospholipids and paraoxonase activity with coronary heart disease in postmenopausal women.
Acta physiologica Scandinavica 2002;176(2):123-30.
2002: Uehara Yoshinari; Engel Thomas; Li Zhengchen; Goepfert Christian; Rust Stephan; Zhou Xiaoqin; Langer Claus; Schachtrup Christian; Wiekowski Johannes; Lorkowski Stefan; Assmann Gerd; von Eckardstein Arnold
Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1.
Diabetes 2002;51(10):2922-8.
2002: Berger Klaus; von Eckardstein Arnold; Trenkwalder Claudia; Rothdach Andreas; Junker Ralf; Weiland Stephan Karl
Iron metabolism and the risk of restless legs syndrome in an elderly general population--the MEMO-Study.
Journal of neurology 2002;249(9):1195-9.
2002: Langer Claus; Gansz Barbara; Goepfert Christian; Engel Thomas; Uehara Yoshinari; von Dehn Gerlinde; Jansen Hans; Assmann Gerd; von Eckardstein Arnold
Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages.
Biochemical and biophysical research communications 2002;296(5):1051-7.
2002: Reinecke Holger; Bogdanski Janina; Woltering Anne; Breithardt G; Assmann Gerd; Kerber Sebastian; von Eckardstein Arnold
Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women.
The American journal of cardiology 2002;90(4):364-8.
2002: Kratz Mario; Gülbahçe Esma; von Eckardstein Arnold; Cullen Paul; Cignarella Andrea; Assmann Gerd; Wahrburg Ursel
Dietary mono- and polyunsaturated fatty acids similarly affect LDL size in healthy men and women.
The Journal of nutrition 2002;132(4):715-8.
2002: Nofer Jerzy-Roch; Kehrel Beate; Fobker Manfred; Levkau Bodo; Assmann Gerd; von Eckardstein Arnold
HDL and arteriosclerosis: beyond reverse cholesterol transport.
Atherosclerosis 2002;161(1):1-16.
2002: Zhou Xiaoqin; Engel Thomas; Goepfert Christian; Erren Michael; Assmann Gerd; von Eckardstein Arnold
The ATP binding cassette transporter A1 contributes to the secretion of interleukin 1beta from macrophages but not from monocytes.
Biochemical and biophysical research communications 2002;291(3):598-604.
2002: Bellosta S; Bernini F; Chinetti G; Cignarella A; Cullen P; von Eckardstein A; Exley A; Freeth J; Goddard M; Hofker M; Kanters E; Kovanen P; Lorkowski S; Pentikäinen M; Printen J; Rauterberg J; Ritchie A; Staels B; Weitkamp B; de Winther M;
Macrophage function and stability of the atherosclerotic plaque: progress report of a European project.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2002;12(1):3-11.
2002: Kronenberg Florian; Kuen Erich; Ritz Eberhard; König Paul; Kraatz Günter; Lhotta Karl; Mann Johannes F E; Müller Gerhard A; Neyer Ulrich; Riegel Werner; Riegler Peter; Schwenger Vedat; von Eckardstein Arnold
Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure.
Journal of the American Society of Nephrology : JASN 2002;13(2):461-9.
2002: Zhou Xiaoqin; von Eckardstein Arnold
Effect of HDL and apoAI on PGE2 production by monocyte-derived macrophages.
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2002;22(4):270-2.
2001: von Eckardstein A; Schmiddem K; Hövels A; Gülbahçe E; Schuler-Lüttmann S; Elbers J; Helmond F; Bennink H J; Assmann G
Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity.
Atherosclerosis 2001;159(2):433-9.
2001: Zitzmann M; Brune M; Kornmann B; Gromoll J; von Eckardstein S; von Eckardstein A; Nieschlag E
The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity.
The Journal of clinical endocrinology and metabolism 2001;86(10):4867-73.
2001: von Eckardstein A; Fischer F; Schulte H; Tataru M; Köhler E; Assmann G
Association of serum apolipoprotein A-I (but not high-density lipoprotein cholesterol) with healed myocardial infarction in men independent of serum insulin and C-peptide.
The American journal of cardiology 2001;88(7):723-6.
2001: Nofer J R; Levkau B; Wolinska I; Junker R; Fobker M; von Eckardstein A; Seedorf U; Assmann G
Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids.
The Journal of biological chemistry 2001;276(37):34480-5.
2001: Kuch B; Bobak M; Fobker M; Junker R; von Eckardstein A; Marmot M; Hense H W
Associations between homocysteine and coagulation factors--a cross-sectional study in two populations of central Europe.
Thrombosis research 2001;103(4):265-73.
2001: Von Eckardstein A; Langer C; Engel T; Schaukal I; Cignarella A; Reinhardt J; Lorkowski S; Li Z; Zhou X; Cullen P; Assmann G
ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(9):1555-61.
2001: von Eckardstein A; Assmann G
Clinical implications of elevated lipoprotein(a).
Current atherosclerosis reports 2001;3(4):267-70.
2001: Tataru M C; Schulte H; von Eckardstein A; Heinrich J; Assmann G; Koehler E
Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Coronary artery disease 2001;12(3):157-65.
2001: Nofer J R; Junker R; Pulawski E; Fobker M; Levkau B; von Eckardstein A; Seedorf U; Assmann G; Walter M
High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway.
Thrombosis and haemostasis 2001;85(4):730-5.
2001: von Eckardstein A; Schulte H; Cullen P; Assmann G
Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.
Journal of the American College of Cardiology 2001;37(2):434-9.
2001: Nowak-Göttl U; Junker R; Kreuz W; von Eckardstein A; Kosch A; Nohe N; Schobess R; Ehrenforth S;
Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors.
Blood 2001;97(4):858-62.
2001: Nowak-Göttl U; Sträter R; Kosch A; von Eckardstein A; Schobess R; Luigs P; Nabel P; Vielhaber H; Kurnik K; Junker R
The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.
European journal of haematology 2001;66(1):57-62.
2001: von Eckardstein A; Nofer J R; Assmann G
High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(1):13-27.
2001: Kuch B; Hense H W; Sinnreich R; Kark J D; von Eckardstein A; Sapoznikov D; Bolte H D
Determinants of short-period heart rate variability in the general population.
Cardiology 2001;95(3):131-8.
2000: Nofer J R; Fobker M; Höbbel G; Voss R; Wolinska I; Tepel M; Zidek W; Junker R; Seedorf U; von Eckardstein A; Assmann G; Walter M
Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux.
Biochemistry 2000;39(49):15199-207.
2000: von Eckardstein A; Assmann G
Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?
Current opinion in lipidology 2000;11(6):627-37.
2000: Pieke B; von Eckardstein A; Gülbahçe E; Chirazi A; Schulte H; Assmann G; Wahrburg U
Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(10):1286-96.
2000: von Eckardstein A; Schulte H; Assmann G
Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.
The Journal of clinical endocrinology and metabolism 2000;85(9):3101-8.
2000: Kronenberg F; Stühlinger M; Trenkwalder E; Geethanjali F S; Pachinger O; von Eckardstein A; Dieplinger H
Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease.
Journal of the American College of Cardiology 2000;36(3):751-7.
2000: Kamischke A; Plöger D; Venherm S; von Eckardstein S; von Eckardstein A; Nieschlag E
Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.
Clinical endocrinology 2000;53(1):43-52.
2000: Tataru M C; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris.
European heart journal 2000;21(12):1000-8.
2000: Schuler-Lüttmann S; Zhu Y; Hoffmann M; März W; Feussner G; Wieland H; Assmann G; von Eckardstein A
Cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas.
Metabolism: clinical and experimental 2000;49(6):770-7.
2000: Kronenberg F; Kuen E; Ritz E; Junker R; König P; Kraatz G; Lhotta K; Mann J F; Müller G A; Neyer U; Riegel W; Reigler P; Schwenger V; Von Eckardstein A
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
Journal of the American Society of Nephrology : JASN 2000;11(1):105-15.
1999: Nowak-Göttl U; Sträter R; Heinecke A; Junker R; Koch H G; Schuierer G; von Eckardstein A
Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.
Blood 1999;94(11):3678-82.
1999: Schlegel W; Petersdorf L I; Junker R; Schulte H; Ebert C; Von Eckardstein A
The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
Clinical endocrinology 1999;51(5):643-51.
1999: Tataru M C; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
European heart journal 1999;20(20):1493-502.
1999: Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard P H; Bruckert E; Assmann G; von Eckardstein A
Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
Journal of molecular medicine (Berlin, Germany) 1999;77(8):614-22.
1999: Nowak-Göttl U; Junker R; Hartmeier M; Koch H G; Münchow N; Assmann G; von Eckardstein A
Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.
Circulation 1999;100(7):743-8.
1999: Bobak M; Hense H W; Kark J; Kuch B; Vojtisek P; Sinnreich R; Gostomzyk J; Bui M; von Eckardstein A; Junker R; Fobker M; Schulte H; Assmann G; Marmot M
An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men.
International journal of epidemiology 1999;28(3):437-44.
1999: Büchter D; von Eckardstein S; von Eckardstein A; Kamischke A; Simoni M; Behre H M; Nieschlag E
Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception.
The Journal of clinical endocrinology and metabolism 1999;84(4):1244-9.
1999: Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen P T
Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(4):1066-74.
1999: Daum U; Leren T P; Langer C; Chirazi A; Cullen P; Pritchard P H; Assmann G; von Eckardstein A
Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers.
Journal of lipid research 1999;40(3):486-94.
1999: Büchter D; Behre H M; Kliesch S; Chirazi A; Nieschlag E; Assmann G; von Eckardstein A
Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107(8):522-9.
1998: Cullen P; von Eckardstein A; Assmann G
Diagnosis and management of new cardiovascular risk factors.
European heart journal 1998;19 Suppl O():O13-9.
1998: Assmann G; Schulte H; Funke H; von Eckardstein A
The emergence of triglycerides as a significant independent risk factor in coronary artery disease.
European heart journal 1998;19 Suppl M():M8-14.
1998: Rust S; Walter M; Funke H; von Eckardstein A; Cullen P; Kroes H Y; Hordijk R; Geisel J; Kastelein J; Molhuizen H O; Schreiner M; Mischke A; Hahmann H W; Assmann G
Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy.
Nature genetics 1998;20(1):96-8.
1998: Cignarella A; Brennhausen B; von Eckardstein A; Assmann G; Cullen P
Differential effects of lovastatin on the trafficking of endogenous and lipoprotein-derived cholesterol in human monocyte-derived macrophages.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(8):1322-9.
1998: Zhu Y; Bellosta S; Langer C; Bernini F; Pitas R E; Mahley R W; Assmann G; von Eckardstein A
Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7585-90.
1998: von Eckardstein A; Huang Y; Kastelein J J; Geisel J; Real J T; Kuivenhoven J A; Miccoli R; Noseda G; Assmann G
Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients.
Atherosclerosis 1998;138(1):25-34.
1998: von Eckardstein A; Chirazi A; Schuler-Lüttmann S; Walter M; Kastelein J J; Geisel J; Real J T; Miccoli R; Noseda G; Höbbel G; Assmann G
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I.
Journal of lipid research 1998;39(5):987-98.
1998: von Eckardstein A; Assmann G
High density lipoproteins and reverse cholesterol transport: lessons from mutations.
Atherosclerosis 1998;137 Suppl():S7-11.
1998: Cullen P; Cignarella A; Brennhausen B; Mohr S; Assmann G; von Eckardstein A
Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.
The Journal of clinical investigation 1998;101(8):1670-7.
1998: Bänsch D; Chen-Haudenschild C; Dirkes-Kersting A; Schulte H; Assmann G; von Eckardstein A
Basal growth hormone levels in women are positively correlated with high-density lipoprotein cholesterol and apolipoprotein A-I independently of insulin-like growth factor 1 or insulin.
Metabolism: clinical and experimental 1998;47(3):339-44.
1997: Huang Y; Zhu Y; Langer C; Raabe M; Wu S; Wiesenhütter B; Seedorf U; Maeda N; Assmann G; von Eckardstein A
Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(10):2010-9.
1997: von Eckardstein A; Kliesch S; Nieschlag E; Chirazi A; Assmann G; Behre H M
Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a).
The Journal of clinical endocrinology and metabolism 1997;82(10):3367-72.
1997: Bänsch D; Dirkes-Kersting A; Schulte H; Assmann G; von Eckardstein A
Basal growth hormone levels are positively correlated with high-density lipoprotein cholesterol levels in women.
Metabolism: clinical and experimental 1997;46(9):1039-43.
1997: Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
Journal of lipid research 1997;38(6):1242-53.
1997: Leren T P; Bakken K S; Daum U; Ose L; Berg K; Assmann G; von Eckardstein A
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
Journal of lipid research 1997;38(1):121-31.
1996: von Eckardstein A
Cholesterol efflux from macrophages and other cells.
Current opinion in lipidology 1996;7(5):308-19.
1996: von Eckardstein S; von Eckardstein A; Bender H G; Schulte H; Assmann G
Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1996;10(5):311-8.
1996: Assmann G; Schulte H; von Eckardstein A; Huang Y
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport.
Atherosclerosis 1996;124 Suppl():S11-20.
1996: von Eckardstein A; Huang Y; Wu S; Assmann G
Uptake, transfer, and esterification of cell-derived cholesterol in plasma of patients with familial HDL-deficiency.
Zeitschrift für Gastroenterologie 1996;34 Suppl 3():143-4.
1996: von Eckardstein A; Jauhiainen M; Huang Y; Metso J; Langer C; Pussinen P; Wu S; Ehnholm C; Assmann G
Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL.
Biochimica et biophysica acta 1996;1301(3):255-62.
1996: Assmann G; Schulte H; von Eckardstein A
Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men.
The American journal of cardiology 1996;77(14):1179-84.
1996: Wiebusch H; Funke H; Bruin T; Bucher H; von Eckardstein A; Kastelein J J; Assmann G
Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia.
Human mutation 1996;8(4):381-3.
1995: Huang Y; von Eckardstein A; Wu S; Assmann G
Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma.
The Journal of clinical investigation 1995;96(6):2693-701.
1995: von Eckardstein A; Huang Y; Wu S; Sarmadi A S; Schwarz S; Steinmetz A; Assmann G
Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(10):1755-63.
1995: Huang Y; von Eckardstein A; Wu S; Langer C; Assmann G
Generation of pre-beta 1-HDL and conversion into alpha-HDL. Evidence for disturbed HDL conversion in Tangier disease.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(10):1746-54.
1995: Huang Y; von Eckardstein A; Wu S; Assmann G
Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(9):1412-8.
1995: Navalesi R; Miccoli R; Odoguardi L; Funke H; von Eckardstein A; Wiebusch H; Assmann G
Genetically determined absence of HDL-cholesterol and coronary atherosclerosis.
Lancet 1995;346(8976):708-9.
1995: Nofer J R; von Eckardstein A; Wiebusch H; Weng W; Funke H; Schulte H; Köhler E; Assmann G
Screening for naturally occurring apolipoprotein A-I variants: apo A-I(delta K107) is associated with low HDL-cholesterol levels in men but not in women.
Human genetics 1995;96(2):177-82.
1995: Bolibar I; Thompson S G; von Eckardstein A; Sandkamp M; Assmann G
Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent, and comprehensive. ECAT Angina Pectoris Study Group.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(8):1035-42.
1995: Wiebusch H; Nofer J R; von Eckardstein A; Funke H; Wahrburg U; Martin H; Köhler E; Assmann G
Electrophoretic screening for human apolipoprotein C-II variants: repeated identification of apolipoprotein C-II(K19T).
Journal of molecular medicine (Berlin, Germany) 1995;73(7):373-8.
1995: von Eckardstein A; Huang Y; Wu S; Funke H; Noseda G; Assmann G
Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(5):691-703.
1995: Walek T; von Eckardstein A; Schulte H; Assmann G
Effect of hypertriglyceridaemia on lipoprotein (a) serum concentrations.
European journal of clinical investigation 1995;25(5):311-6.
1995: Nofer J R; von Eckardstein A; Assmann G
Mannitol prevents methionine sulphoxidation mediated electrophoretic heterogeneity of apolipoprotein A-I.
Biomedical chromatography : BMC 1995;9(1):28-31.
1994: Römling R; von Eckardstein A; Funke H; Motti C; Fragiacomo G C; Noseda G; Assmann G
A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(12):1915-22.
1994: von Eckardstein A; Huang Y; Assmann G
Physiological role and clinical relevance of high-density lipoprotein subclasses.
Current opinion in lipidology 1994;5(6):404-16.
1994: Lüttmann S; von Eckardstein A; Wei W; Funke H; Köhler E; Mahley R W; Assmann G
Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient.
Journal of lipid research 1994;35(8):1431-40.
1994: von Eckardstein A; Funke H; Chirazi A; Chen-Haudenschild C; Schulte H; Schönfeld R; Köhler E; Schwarz S; Steinmetz A; Assmann G
Sex-specific effects of the glutamine/histidine polymorphism in apo A-IV on HDL metabolism.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(7):1114-20.
1994: Huang Y; von Eckardstein A; Wu S; Maeda N; Assmann G
A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(5):1834-8.
1994: von Eckardstein A; Malinow M R; Upson B; Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(3):460-4.
1993: Assmann G; von Eckardstein A; Funke H
High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.
Circulation 1993;87(4 Suppl):III28-34.
1993: Huang Y; von Eckardstein A; Assmann G
Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(3):445-58.
1993: Funke H; von Eckardstein A; Pritchard P H; Hornby A E; Wiebusch H; Motti C; Hayden M R; Dachet C; Jacotot B; Gerdes U
Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease.
The Journal of clinical investigation 1993;91(2):677-83.
1993: von Eckardstein A; Castro G; Wybranska I; Theret N; Duchateau P; Duverger N; Fruchart J C; Ailhaud G; Assmann G
Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
The Journal of biological chemistry 1993;268(4):2616-22.
1993: von Eckardstein A; Heinrich J; Funke H; Schulte H; Schönfeld R; Köhler E; Steinmetz A; Assmann G
Glutamine/histidine polymorphism in apo A-IV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(2):240-6.
1992: von Eckardstein A; Funke H; Schulte M; Erren M; Schulte H; Assmann G
Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.
American journal of human genetics 1992;50(5):1115-28.
1991: von Eckardstein A; Walter M; Holz H; Benninghoven A; Assmann G
Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III.
Journal of lipid research 1991;32(9):1465-76.
1991: Funke H; von Eckardstein A; Pritchard P H; Albers J J; Kastelein J J; Droste C; Assmann G
A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(11):4855-9.
1991: von Eckardstein A; Holz H; Sandkamp M; Weng W; Funke H; Assmann G
Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
The Journal of clinical investigation 1991;87(5):1724-31.
1991: Funke H; von Eckardstein A; Pritchard P H; Karas M; Albers J J; Assmann G
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.
The Journal of clinical investigation 1991;87(1):371-6.
1990: von Eckardstein A; Funke H; Walter M; Altland K; Benninghoven A; Assmann G
Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.
The Journal of biological chemistry 1990;265(15):8610-7.
1989: von Eckardstein A; Funke H; Henke A; Altland K; Benninghoven A; Assmann G
Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.
The Journal of clinical investigation 1989;84(6):1722-30.

Sign-in to see more